R. Stolarek et al., EFFECT OF VARIOUS AGONISTS ON NITRIC-OXIDE GENERATION BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES, International journal of clinical & laboratory research, 28(2), 1998, pp. 104-109
Nitric oxide,generation is involved in a range of diseases involving p
olymorphonuclear leukocytes. The aim of this study was to determine wh
ether human polymorphonuclear leukocytes are able to generate nitric o
xide and to investigate the time course of its generation after stimul
ation with 10(-7) M N-formyl-methionyl-leucyl-phenylalanine, 60 ng/ml
phorbol myristate acetate, 10(-7) M? concanavalin A, and 10(-7) M plat
elet activating factor. Stimulation of human polymorphonuclear leukocy
tes with N-formyl-methionyl-leucyl-phenylalanine and phorbol myristate
acetate caused sustained nitric oxide generation, reaching maximal va
lues of 1,105+/-361 nM (n=32) and 628+/-119 nM (n=30), respectively. P
latelet activating factor did not affect nitric oxide production (maxi
mal value 29+/-7 nM, n=8), whereas concanavalin A caused only a slight
increase (102+/-24 nM, n=8) when compared with resting cells control
(26+/-6 nM, n=8). Human polymorphonuclear leukocytes were able to resp
ond to both consecutive and alternate N-formyl-methionyl-leucyl-phenyl
alanine and phorbol myristate acetate stimulation with nitric oxide ge
neration. Nitric oxide generation was inhibited by specific inhibitors
(N-omega-nitro-L-arginine and N(omega-)monomethyl-L-arginine) and res
tored with L-arginine. We provide, to our knowledge, the first direct
evidence that human neutrophils generate nitric oxide.